X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

EVGN

Closed

Evogene

1.34
+0.06 (+4.69%)
Last Update: 01 Jul 2025 23:17:00
Yesterday: 1.28
Day's Range: 1.26 - 1.44
Send
When Written:
 
0.63
Evogene is a biotechnology company that specializes in computational genomics and develops products for agriculture, food, and healthcare industries. The company is headquartered in Rehovot, Israel, and was founded in 2002.

Evogene's technology platform includes proprietary algorithms and genomic databases that enable the discovery of new genes, traits, and pathways in plants, microbes, and human cells. The company uses this platform to develop innovative products such as crop seeds with improved yield, drought resistance, and disease tolerance; microbial solutions for sustainable agriculture and food production; and drug candidates for cancer and inflammation.

Evogene collaborates with leading companies and institutions in the agrochemical, seed, and pharmaceutical industries, including Monsanto, Syngenta, BASF, and the Mayo Clinic. The company is publicly traded on the Tel Aviv Stock Exchange and the NASDAQ under the ticker symbol EVGN.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X